Trilobatin combats copper overload-induced cognitive impairment by blocking FDX1-dependent cuproptosis and restoring mitochondrial dynamics
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Copper homeostasis disorder triggers neuronal cuproptosis and progressive cognitive degeneration, lacking effective natural therapeutic agents. Trilobatin (TLB), a dihydrochalcone from Lithocarpus polystachyus Rehd., was reported to inhibit FDX1, yet its systematic neuroprotective mechanism against copper overload remains unclear. Herein, chronic CuSO 4 gavage mouse model and CuSO 4 -exposed HT22 hippocampal neurons were constructed. Behavioral tests confirmed TLB dose-dependently rescued copper-induced memory deficits. Mechanistically, TLB bidirectionally regulated copper transporters SLC31A1/ATP7B to reduce intracellular copper deposition, alleviated oxidative stress, restored mitochondrial fusion-fission balance and ultrastructural integrity. TLB suppressed FDX1-driven cuproptotic signaling, normalized disrupted TCA cycle and mitochondrial respiratory function. FDX1 siRNA knockdown further verified FDX1 as the indispensable mediator of TLB’s neuroprotection. Collectively, TLB ameliorates copper overload-mediated hippocampal injury and cognitive dysfunction by inhibiting FDX1-dependent cuproptosis and restoring mitochondrial metabolism, offering a promising candidate for metal dyshomeostasis-related neurodegenerative diseases.
